Crescent Capital BDC, Inc. (NASDAQ: CCAP) had its price target lowered by analysts at Keefe, Bruyette & Woods from $20.00 to $18.50. They now have an "outperform" rating on the stock.
Is the Options Market Predicting a Spike in Crescent Capital BDC (CCAP) Stock? [Yahoo! Finance]
https://seekingalpha.com/article/4765184-crescent-capital-q4-earnings-showing-signs-of-weakness-rating-downgrade [Seeking Alpha]
Crescent Capital BDC, Inc. (NASDAQ: CCAP) had its price target lowered by analysts at Wells Fargo & Company from $19.00 to $18.00. They now have an "equal weight" rating on the stock.
Crescent Capital BDC, Inc. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]